Ch 5: Compounding Flashcards
FED Select all. Compounded drugs should be: A) Based on a prescription B) FDA-approved C) Commercially available D) Follow USP standards
A, D
Compounded drugs are NOT commercially available, and are made for an individual pt based on a prescription, and are not FDA-approved
FED Who sets the standards for compounding preparations
USP
FED The 2012 contamination issue located at the ____ that was responsible for an outbreak of ____ caused a subsequent change to legislation involving the FDCA
New England Compounding Center
Fungal meningitis
FED The fungal meningitis outbreak at NECC resulted in the development of what piece of legislation
The Drug Quality and Security Act, which was an alteration to the FDCA
FED The DQSA breaks down sections 503A into ___ and 503B into ___
503A = traditional compounding 503B = outsourcing facilities
FED Preparing an IV and making magic mouthwash is likely pursuant to
A) 503A
B) 503B
503A = traditional compounding
FED Compounding medication for bulk office use is likely pursuant to:
A) 503A
B) 503B
B) 503B = outsourcing facilities
FED Select all. Which of the following follow both USP and CGMPs?
A) 503A
B) 503B
C) Manufacturing
503B and manufacturing, but 503A does NOT follow CGMPs
FED Compounding for bulk medical office use is prohibited under which, 503A or 503B
503A
FED A provider stocks a professionally compounded medication for office use. Where did he likely source these from?
A) A traditional compounding facility
B) An outsourcing facility
B) outsourcing facility
FED Who regulates a 503A pharmacy vs a 503B pharmacy
503A = State boards 503B = FDA, state license may be required
FED Select all. Which requires registration with the FDA?
A) Drug manufacturer
B) 503A traditional compounding facility
C) 503B outsourcing compounding facility
Drug manufacturer & 503B outsourcing facility
FED Which of the following is likely to require a patient-specific prescription prior to preparing a drug product?
A) 503A facility
B) 503B facility
C) Drug manufacturer
A–503A pharmacies provide traditional compounding based on patient-specific prescriptions
FED T/F Physicians and other healthcare practitioners are permitted by federal law to compound in medical offices
True
API abbreviation means
active pharmaceutical ingredients
FED Ingredients that are acceptable for use in compounding will be listed:
A) In the USP National Formulary (USP-NF)
B) In the Food Chemicals Codex (FCC)
C) In either A or B
D) In both A & B
C = either the USP-NF or the Food Chemicals Codex
FED Under what circumstances can a compounding ingredient that is not manufactured at an FDA-registered facility be used to compound?
A) Always, there is no FDA requirement for ingredients since compounding products are not FDA approved
B) If a Certificate of Analysis (CoA) is obtained to confirm quality
C) So as long as the ingredients are both USP-NF approved and FCC approved
B = it is preferable for ingredients to be manufactured at an FDA-registered facility, if not, a CoA should be obtained to confirm the quality
FED If there is no expiration date on a compounding ingredient upon receipt, what should the pharmacist do?
A) Label it to be 1 year from date of receipt
B) Label it to be 3 years from the date of receipt
C) Send the product back to the supplier
B: if component without expiration date, RPh assigns a conservative date that is no more than 3 years from the date of receipt
FED If a pharmacist assigns an expiration date to a compounding ingredient, what should the label include? A) The date of receipt B) Assigned expiration date C) NDC D) Both A&B E) All of the above
If RPh assigns the expiration to a compounding ingredient, it should be no later than 3 years from date of receipt, and label should have the expiration date and the date of receipt
FED A compounded preparation for a per rectum medication is considered to be:
A) Sterile
B) Nonsterile
Nonsterile
FED Select all. Per USP 795, nonsterile compounding may:
A) Be prepped in a distinctly separate location from sterile preps
B) Be performed in a PEC at minimum
C) Be performed in ambient/room air
D) Be separated from the dispensing part of the pharmacy
A) True: separate location from sterile preps
B) False, can be done in room air
C) True, can be done in room air
D) True, should be separated from dispensing part of the pharmacy
FED A technician comes upon compounding supplies, tools, and excipients stored on the floor. Is this of concern?
A) If they are for non-sterile compounding, no
B) If they are for sterile compounding, this is wrong
C) Pharmaceutical ingredients for compounding should not be stored on the floor, but the supplies are fine
D) No compounding components are to be stored on the floor for compounding of any sort
D = no compounding components (drugs, excipients, equipment, containers) are to be stored on the floor for any type of compounding
FED A tech has compounded a nonsterile, oral formulation that contains water. What is the BUD and storing temp?
Nonsterile, water, oral = fridge, 14 days BUD
FED An RPh compounded a nonsterile, oral formulation that does not contain water. What is the BUD and storing temp?
Nonsterile, no water = room temp 6 months
FED An RPh compounded a nonsterile, non-oral formulation that contains water. What is the BUD and storing temp?
Room temp, 30 days
FED A tech compounded a nonsterile non-oral prescription that contains poloxamer gel. What is the BUD and storing temp? A) Fridge, 14 days B) Fridge, 30 days C) Room temp, 14 days D) Room temp, 30 days
D. Poloxamer gel contains water. Non oral = room temp, 30 days
FED T/F The BUD of a nonsterile compounded prep can be extended if stability data is obtained that shows a longer stability period
True. I’m not sure if this applies to sterile or not
FED Select all. Which of the following would likely be considered sterile preps if compounded? A) IV B) Oral C) Bladder irrigation D) Rectal suppository E) Nasal inhalations
A) IV = sterile B) oral = nonsterile C) bladder irrigation = sterile D) Rectal supp = nonsterile E) Nasal inhalation = nonsterile (but pulmonary inhalations ARE sterile)
FED When compounding in critical areas closest to exposed sterile drugs, the air should be at least ISO
5 or LESS…. meaning ISO 4 is fine, but ISO 6 is not
FED According to ISO ratings, ambient or room air is considered: A) ISO 10 B) ISO 8 C) ISO 7 D) ISO 6 E) Unclassified; not rated
E, ambient room air is not ISO rated
FED If using a PEC for sterile compounding, the space should also include:
A) A SEC
B) An anteroom
C) All of the above
C. Should be anteroom + SEC + PEC…… or CAI + SCA
FED Which of the following are acceptable for a sterile compounding space? A) Anteroom + SEC + PEC B) Garb room + anteroom + SEC + PEC C) CAI + SCA D) A&C E) All of the above
D.
Anteroom + SEC + PEC, or
CAI + SCA
FED What might a CAI also be called
Glove box
FED What might the SEC also be referred to as
Buffer area. NOT the anteroom
FED What purpose does the anteroom serve
A) Provide a buffer of relatively clean air around the PEC or PECs
B) Comprises a separate area for hazardous compounding
C) Connects the rest of the pharmacy to the SEC to provide a place for garbing
C
FED Garbing and handwashing take place: A) Before entering the anteroom B) In the anteroom C) Before entering the buffer area D) In the buffer area
B, garding and handwashing takes place in the anteroom, prior to entering the SEC (SEC = buffer area)
FED The buffer area, or SEC, should be at least ISO
7
FED The anteroom should be at least ISO __ for nonhazardous sterile compounding, or ISO ___ for hazardous sterile compounding
ISO 8 for pos pres non-HD
ISO 7 for neg pres HD
FED If performing sterile compounding in a CAI located in an SCA, the ISO rating of the SCA should be classified as: A) ISO 5 B) ISO 7 C) ISO 8 D) Is it not classified
A segregated compounding area is a separate area, the air in an SCA is not classified according to ISO standards
FED Hazardous compounding shouldn’t be done in an area with __ air pressure
Positive…. HDs need negative air pressure
FED Which type of STERILE compounding uses NON-sterile ingredients or equipment that must be sterilized prior to use?
A) Low risk
B) Medium risk
C) High risk
C) High risk. High risk sterile compounding is not common
FED Fill in the following ISO requirements: PEC = ISO \_\_\_ SEC = ISO \_\_\_ Anteroom, HDs = ISO \_\_\_ Anteroom, non-HDs = ISO \_\_\_
PEC = 5
SEC = 7
Anteroom, HD = 7
Anteroom, non-HD = 8
FED Reconstituting a 1g single-dose vial of cefazolin with sterile water and transferring it to a normal saline bag is considered
A) Low risk
B) Medium risk
C) High risk
Low risk, because there are no more than 2 entries into any 1 sterile container/device, and = 3 sterile ingredients including diluent
FED Low risk sterile compounding is considered to be done when there are ____ ingredients including diluent, and no more than ___ entries into any ___ sterile container(s)/device(s)
Low risk sterile compounding = 3 or fewer sterile ingredients including diluent, no more than 2 entries into any 1 sterile container/device
FED Medium risk sterile compounding is considered to be done when ___ sterile ingredients, OR ___ doses of a sterile product are withdrawn from the same vial
Medium risk sterile compounding = greater than 3 sterile ingredients, OR multiple doses of a sterile product withdrawn from same vial to make several CSPs batches
FED Sterile compounding products that are made from nonsterile equipment and ingredients, then sterilized prior to use are considered:
A) Low risk
B) Med risk
C) High risk
C, high risk